Skip to main content

Home

  • Drug Development
    • Our Pipeline
    • Evaluation Pipeline
    • Therapeutic areas
    • Partnering
    • Useful Links
  • News
  • Investors
    • Regulatory News
    • AIM Rule 26
      • Annual and Half Yearly Reports
      • Admission Document & Articles
    • Shareholder communications
    • Investments Calculator
    • Share Alerts
    • Share Series
    • Share price look-up
    • Analyst Research
  • About us
    • Board of Directors and Management Team
    • Strategy and Vision
    • How we work
    • Working with us
    • Collaborative Pipeline
  • Contact us

News

Breadcrumb

  1. News
Category
ValiRx - Operational Update Videocast
Videos and audiocasts

ValiRx - Operational Update Videocast

31 Jan 2023
Dr Cathy Tralau-Stewart
News

ValiRx appoints permanent Chief Scientific Officer

31 Jan 2023
MediCity
News

ValiRx signals launch of new strategy with Nottingham laboratories

31 Jan 2023
ValiRx - Q&A Session
Videos and audiocasts

ValiRx - Question and Answer Videocast

26 Jan 2023
Articles

ValiRx quarterly Q&A webinar: key questions answered

20 Jan 2023
Kevin Cox
Articles

Meet the ValiRx team: Dr Kevin Cox

18 Jan 2023
University laboratory
Articles

Accelerating early stage, academic innovation: the Cytolytix story so far

4 Jan 2023
Zai Ahmad headshot
News

ValiRx appoints preclinical project manager to drive development of triple breast cancer treatment

15 Dec 2022
webinar
Videos and audiocasts

ValiRx Q&A Live Webinar Held on 13th December 2022

14 Dec 2022
webinar
News

ValiRx to host live Q&A shareholder webinar

7 Dec 2022
Suzy Presenting at BOS Manchester 2022
News

ValiRx attends Biotech Outsourcing Strategies 2022

21 Nov 2022
Suzanne Dilly
News

ValiRx CEO introduces Cytolytix at London South East webinar

9 Nov 2022
Videos and audiocasts

LSE Investor Presentation Introducing Cytolytix

9 Nov 2022
Mark Treharne and Cathy Tralau-Stewart at Bio-Europe
News

ValiRx attends Bio-Europe 2022

26 Oct 2022

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Next page Next
  • Last page Last
ValiRx PLC

Contact us

ValiRx Plc
Eliot Park Innovation Centre
4 Barling Way
Nuneaton, CV10 7RH
UK

Tel: +44 (0)2476 796496
Email: info@valirx.com

Registered in England and Wales

Company Number: 3916791
VAT Number: 756 3180 24

UK Registered Office Address
Stonebridge House, Chelmsford Road, Hatfield Heath, England, CM22 7BD

Links

  • Drug Development
    • Our Pipeline
    • Evaluation Pipeline
    • Therapeutic areas
    • Partnering
    • Useful Links
  • News
  • Investors
    • Regulatory News
    • AIM Rule 26
      • Annual and Half Yearly Reports
      • Admission Document & Articles
    • Shareholder communications
    • Investments Calculator
    • Share Alerts
    • Share Series
    • Share price look-up
    • Analyst Research
  • About us
    • Board of Directors and Management Team
    • Strategy and Vision
    • How we work
    • Working with us
    • Collaborative Pipeline
  • Contact us
Terms and Conditions Privacy Policy Accessibility Compliance Corporate Governance Corporate Social Responsibility

Site and its contents Copyright © ValiRx PLC 2023. All rights reserved.
Website Design and Development by Sciad Communications Ltd